Literature DB >> 23399899

Atrophy, fibrosis, and increased PAX7-positive cells in pharyngeal muscles of oculopharyngeal muscular dystrophy patients.

Teresa Gidaro1, Elisa Negroni, Sophie Perié, Massimiliano Mirabella, Jeanne Lainé, Jean Lacau St Guily, Gillian Butler-Browne, Vincent Mouly, Capucine Trollet.   

Abstract

Oculopharyngeal muscular dystrophy (OPMD) is a late-onset autosomal dominant inherited dystrophy caused by an abnormal trinucleotide repeat expansion in the poly(A)-binding-protein-nuclear 1 (PABPN1) gene. Primary muscular targets of OPMD are the eyelid elevator and pharyngeal muscles, including the cricopharyngeal muscle (CPM), the progressive involution of which leads to ptosis and dysphagia, respectively. To understand the consequences of PABPN1 polyalanine expansion in OPMD, we studied muscle biopsies from 14 OPMD patients, 3 inclusion body myositis patients, and 9 healthy controls. In OPMD patient CPM (n = 6), there were typical dystrophic features with extensive endomysial fibrosis and marked atrophy of myosin heavy-chain IIa fibers. There were more PAX7-positive cells in all CPM versus other muscles (n = 5, control; n = 3, inclusion body myositis), and they were more numerous in OPMD CPM versus control normal CPM without any sign of muscle regeneration. Intranuclear inclusions were present in all OPMD muscles but unaffected OPMD patient muscles (i.e. sternocleidomastoid, quadriceps, or deltoid; n = 14) did not show evidence of fibrosis, atrophy, or increased PAX7-positive cell numbers. These results suggest that the specific involvement of CPM in OPMD might be caused by failure of the regenerative response with dysfunction of PAX7-positive cells and exacerbated fibrosis that does not correlate with the presence of PABPN1 inclusions.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23399899     DOI: 10.1097/NEN.0b013e3182854c07

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  23 in total

1.  Ageing and muscular dystrophy differentially affect murine pharyngeal muscles in a region-dependent manner.

Authors:  Matthew E Randolph; Qingwei Luo; Justin Ho; Katherine E Vest; Alan J Sokoloff; Grace K Pavlath
Journal:  J Physiol       Date:  2014-10-17       Impact factor: 5.182

2.  Pharyngeal Satellite Cells Undergo Myogenesis Under Basal Conditions and Are Required for Pharyngeal Muscle Maintenance.

Authors:  Matthew E Randolph; Brittany L Phillips; Hyo-Jung Choo; Katherine E Vest; Yandery Vera; Grace K Pavlath
Journal:  Stem Cells       Date:  2015-12       Impact factor: 6.277

3.  Oropharyngeal dysphagia profiles in individuals with oculopharyngeal muscular dystrophy.

Authors:  L C Tabor; E K Plowman; C Romero-Clark; S Youssof
Journal:  Neurogastroenterol Motil       Date:  2017-11-16       Impact factor: 3.598

4.  Novel mouse models of oculopharyngeal muscular dystrophy (OPMD) reveal early onset mitochondrial defects and suggest loss of PABPN1 may contribute to pathology.

Authors:  Katherine E Vest; Brittany L Phillips; Ayan Banerjee; Luciano H Apponi; Eric B Dammer; Weiting Xu; Dinghai Zheng; Julia Yu; Bin Tian; Grace K Pavlath; Anita H Corbett
Journal:  Hum Mol Genet       Date:  2017-09-01       Impact factor: 6.150

5.  Assessment of PABPN1 nuclear inclusions on a large cohort of patients and in a human xenograft model of oculopharyngeal muscular dystrophy.

Authors:  Fanny Roth; Jamila Dhiab; Alexis Boulinguiez; Hadidja-Rose Mouigni; Saskia Lassche; Elisa Negroni; Laura Muraine; Alix Marhic; Alison Oliver; Jeanne Lainé; Andrée Rouche; Erin K O'Ferrall; Baziel van Engelen; Coen Ottenheijm; Hagar Greif; Sergiu Blumen; Jean Lacau St Guily; Sophie Perie; Gillian Butler-Browne; Vincent Mouly; Capucine Trollet
Journal:  Acta Neuropathol       Date:  2022-10-05       Impact factor: 15.887

Review 6.  PABPN1: molecular function and muscle disease.

Authors:  Ayan Banerjee; Luciano H Apponi; Grace K Pavlath; Anita H Corbett
Journal:  FEBS J       Date:  2013-05-24       Impact factor: 5.542

7.  Transduction Efficiency of Adeno-Associated Virus Serotypes After Local Injection in Mouse and Human Skeletal Muscle.

Authors:  Laura Muraine; Mona Bensalah; Jamila Dhiab; Gonzalo Cordova; Ludovic Arandel; Alix Marhic; Maud Chapart; Stéphane Vasseur; Sofia Benkhelifa-Ziyyat; Anne Bigot; Gillian Butler-Browne; Vincent Mouly; Elisa Negroni; Capucine Trollet
Journal:  Hum Gene Ther       Date:  2020-01-24       Impact factor: 5.695

8.  Human skeletal muscle-derived CD133(+) cells form functional satellite cells after intramuscular transplantation in immunodeficient host mice.

Authors:  Jinhong Meng; Soyon Chun; Rowan Asfahani; Hanns Lochmüller; Francesco Muntoni; Jennifer Morgan
Journal:  Mol Ther       Date:  2014-02-26       Impact factor: 11.454

9.  Anti-prion Drugs Targeting the Protein Folding Activity of the Ribosome Reduce PABPN1 Aggregation.

Authors:  Aline Bamia; Maha Sinane; Rima Naït-Saïdi; Jamila Dhiab; Frédéric Bihel; Cécile Voisset; Marc Keruzoré; Phu Hai Nguyen; Agathe Bertho; Flavie Soubigou; Sophie Halliez; Marc Blondel; Capucine Trollet; Martine Simonelig; Gaëlle Friocourt; Vincent Béringue
Journal:  Neurotherapeutics       Date:  2021-02-02       Impact factor: 7.620

10.  204th ENMC International Workshop on Biomarkers in Duchenne Muscular Dystrophy 24-26 January 2014, Naarden, The Netherlands.

Authors:  Alessandra Ferlini; Kevin M Flanigan; Hanns Lochmuller; Francesco Muntoni; Peter A C 't Hoen; Elizabeth McNally
Journal:  Neuromuscul Disord       Date:  2014-09-11       Impact factor: 4.296

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.